Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Equities

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2025-07-09 5-day change 1st Jan Change
19.50 CNY -0.76% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. -1.47% +6.15%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Capitalization 8.87B 1.23B 1.05B 981M 909M 1.69B 106B 1.89B 11.75B 4.47B 49.59B 4.63B 4.53B 181B P/E ratio 2025 *
20.2x
P/E ratio 2026 * 17.3x
Enterprise value 9.48B 1.32B 1.13B 1.05B 972M 1.81B 113B 2.02B 12.56B 4.78B 53.02B 4.95B 4.85B 193B EV / Sales 2025 *
2.62x
EV / Sales 2026 * 2.13x
Free-Float
51.84%
Yield 2025 *
2.29%
Yield 2026 * 2.81%
More valuation ratios * Estimated data
Dynamic Chart
Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. Jun. 13 CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. Apr. 30 CI
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. Apr. 29 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 Apr. 25 CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. Apr. 02 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 Apr. 02 CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. Jan. 02 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire 56.31% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for approximately CNY 104 million. Dec. 13 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire an additional 15% stake in Tianjin Ruihe Biotechnology Co., Ltd. from Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 1. Dec. 13 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of 40% stake in Tianjin Ruihe Biotechnology Co., Ltd. from Tianjin Ruipu Pharmaceutical Technology Co., Ltd. for CNY 1. Dec. 13 CI
Tianjin Ringpu Bio-Technology Plans to Acquire 15% Stake in Zhongrui Huapu Technology Nov. 08 MT
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire 15% stake in Zhongrui Huapu Technology Co., Ltd. from Li Shoujun, Liang Wu, Su Yalada, Li Xudong, Bao Haili, and Zhou Zhonghua for approximately CNY 130 million. Nov. 07 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 160 million worth of its shares. Nov. 04 CI
More news
1 day-0.76%
1 week-1.47%
Current month+0.41%
1 month-7.32%
3 months+3.67%
6 months+11.30%
Current year+6.15%
More quotes
1 week 19.45
Extreme 19.45
20.19
1 month 18.98
Extreme 18.98
21.55
Current year 16.08
Extreme 16.08
28.9
1 year 11.25
Extreme 11.25
28.9
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
44.41
10 years 6.3
Extreme 6.3
44.41
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 2008-05-11
Director of Finance/CFO 50 2022-04-27
Corporate Officer/Principal 44 2020-10-26
Director TitleAgeSince
Chairman 62 2008-05-11
Chairman 62 2018-12-23
Director/Board Member 52 2019-12-24
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.76%-1.47%+48.85%+9.92% 1.25B
+0.30%-0.58%-9.78%-11.07% 70.25B
+0.20%+2.43%+6.03%-27.73% 7.33B
-0.72%-0.93%+1.05%+0.31% 3.63B
+1.46%+9.29%-0.86%-7.96% 3.35B
-0.80%+5.82%+20.23%-9.64% 2.35B
+4.22%+17.92%+79.17%+60.56% 1.22B
-0.95%+0.14%+4.12%-41.50% 1.05B
+2.67%+3.63%-18.35%-35.40% 1.04B
-0.31%+1.46%+18.68%-38.27% 1.03B
Average +0.53%+2.57%+14.91%-10.08% 9.25B
Weighted average by Cap. +0.31%+0.07%-4.68%-11.49%
See all sector performances

Financials

2025 *2026 *
Net sales 3.61B 503M 430M 400M 371M 689M 43.13B 770M 4.79B 1.82B 20.22B 1.89B 1.85B 73.63B 4.21B 587M 501M 466M 432M 803M 50.27B 898M 5.58B 2.12B 23.56B 2.2B 2.15B 85.82B
Net income 450M 62.66M 53.48M 49.77M 46.13M 85.75M 5.37B 95.88M 596M 227M 2.52B 235M 230M 9.17B 525M 73.09M 62.38M 58.06M 53.81M 100M 6.26B 112M 696M 265M 2.94B 274M 268M 10.69B
Net Debt 612M 85.27M 72.78M 67.74M 62.78M 117M 7.31B 130M 811M 309M 3.42B 320M 313M 12.47B 101M 14.11M 12.04M 11.21M 10.39M 19.31M 1.21B 21.59M 134M 51.07M 567M 52.91M 51.8M 2.06B
More financial data * Estimated data
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,900
More about the company
Date Price Change Volume
25-07-09 19.50 ¥ -0.76% 6,867,602
25-07-08 19.65 ¥ -1.06% 11,562,310
25-07-07 19.86 ¥ +0.71% 8,648,118
25-07-04 19.72 ¥ -0.35% 9,188,400
25-07-03 19.79 ¥ +0.97% 10,781,300

End-of-day quote Shenzhen S.E., July 08, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.50CNY
Average target price
26.29CNY
Spread / Average Target
+34.82%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300119 Stock